1Lopez B ,Gonzalez A ,Varo N ,et al. Biochemical assessment of myocardial fibrosis in hypertensive heart disease[ J ]. Hypertension ,2001.38(5 ) :1222-1226.
2Stilli D, Sgoifo A, Macchi E, et al. Myocardial remodeling and arrhythmogenesis in moderate cardinc hypertrophy in rats[J], Am J Physiol Heart Circ Physiol,2001,280( 1 ) : H142-H150.
3Diez J, Lopez B, Gomudea A, et al. Clinical aspects of hypertensive myocardial fibrosis[ J]. Curt Opin Cardiol,2001,16(6) :328-335.
4Lijnen PJ, Petrov VV, Fagard RH. Induction of cardisac fibrisis by sngiotensin II [ J ]. Method, Find Exp Clin Pharmacol.2000 ,22 ( 1 0 ) :709-723.
5Kobayashi N, Nishlkimi T, Horinaka S, et al. Effects of TCV-116 on expression of NOS and adrenomcdullin in failing heart of Dahl salt-sensitive rots[J]. Atherosclerosis .2001.156( 2 ) : 255-265.
6Higashi Y.Kobayashi N.Hara K.et al. Effects of angiotensin II type I receptor antagonist on aitric oxide syntlase exproession and myocardial remodeling in Goldblatt hypertensive rats[ J ]. J Cardiovasc Pharmacol,2000 ,35 (4) :564-571.
7lehihara S,Senbonmatsu T,Price E. ,et al. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy aad cardiac fibrosis in chronic angiotensin II-induced hypenensioa [ J ]. Circulation ,2001,104 ( 3 ) : 346-351.
8Lijnen P. Petrov V. Induction of cardiac fibrosis by aldosterone [ J ]. J Mot Cell Cardiol,2000 ,32 (6) ; 865 -879.
9Tsutamoao T.Wada A,Macda K.et al. Effect of spironolactone on plasma brain natriuretic peptide and legt ventricular remodeling in patients with congestive heart failure[J]. J Am Coll Cardiol,2001,37(5) :1228-1233.
10Hocher B, George I. Rebstock J. et al. Endothelin system-dependent cardiac remodeling in reovascular hypertenaion [ J ]. Hypertension. 1999.33 ( 3 ) : 816-822.
